Michael Reinking, Senior Market Strategist at the NYSE, recaps a week where the Fed cut rates 25 basis points, lifting markets to record highs. U.S.-China talks, including a framework for a TikTok deal, eased tensions and supported global indices. Strong retail sales added momentum, though not inflation adjusted. Small caps outperformed following the Fed’s move. Reinking flags the Trump-Xi call, triple-witching, and PMI and PCE data as next week’s key drivers.

Venture capital is evolving as founder become funders, bringing firsthand experience to the investment table. M13 co-founder Carter Reum has helped shape this shift by backing bold ideas and building platforms that support entrepreneurs from seed to scale. He joins Inside the ICE House for breakfast on the balcony above the NYSE trading floor to share his journey from founder to VC leader, the changing dynamics of venture capital, and how he and his team identify the next generation of game-changing companies.

Matt McLennan, Co-Head of Global Value Investing at First Eagle Investments, joins Bilal Little, Director of Exchange Traded Products at the NYSE, to share his path from Australia and Goldman Sachs to leading one of the industry’s most respected value teams. He discusses First Eagle’s philosophy of resilient wealth creation, with an emphasis on capital preservation, scarcity-driven opportunities, and real assets. McLennan also explores today’s challenging macro backdrop of inflation, debt, and geopolitical risk, and why gold remains a critical hedge.

Phil Rosen of Opening Bell Daily returns to Inside the ICE House to break down the Fed’s expected rate cut and its broader economic impact. He highlights a 911,000-job downward revision as a warning sign for the labor market and explains why Powell’s messaging will be closely watched. Despite soft jobs data, Phil points to strong earnings and AI momentum as key supports for markets. Looking ahead, he cautions that while rate cuts may offer short-term relief, stabilizing the labor market remains the bigger challenge.

The sports media industry is transforming as fans shift to streaming, personalization, and on-demand access. With a vast portfolio of rights, technology, and storytelling, ESPN is redefining how audiences experience live sports and highlights across every screen. Jimmy Pitaro, ESPN's Chairman, goes Inside the ICE House to discuss its direct-to-consumer future, expanded partnerships with the NFL and WWE, and how the network is positioning itself to remain the front door for sports fans in a rapidly changing media landscape.

Eric Criscuolo, Market Strategist at the NYSE, recaps a week of mixed equity performance, with AI and semiconductor stocks leading while Apple lagged. Labor data revisions and rising jobless claims signaled a softer job market, raising Fed policy questions. Inflation data was mixed, with PPI cooling but CPI still elevated. Commodities saw a major copper merger and modest oil gains. Criscuolo flags next week’s Fed decision and Powell’s press conference as key market drivers.

Enveda Biosciences is using AI to decode nature’s vast chemical library and transform it into breakthrough medicines. Founded in 2019 by Viswa Colluru, the company is advancing first-in-class therapies like ENV-294 while cutting the time and cost of drug discovery. Colluru joins Inside the ICE House to share how Enveda is reimagining the playbook for modern medicine and building a healthier future for patients worldwide.

Nimbus Therapeutics is transforming drug discovery with computational chemistry and AI to design small molecules that precisely target disease. CEO Abbas Kazimi, who took the helm in March, is driving a “fail fast” approach that balances discipline with innovation. He joins Inside the ICE House to share how Nimbus is scaling its pipeline and shaping the future of precision medicine.

Michael Reinking, Senior Market Strategist for the NYSE, recaps a choppy week driven by tariff uncertainty, tech earnings misses, and focus on the upcoming jobs report. He notes August ended strong for small and mid-caps, but September’s seasonal weakness and rising global yields remain risks. Labor data showed slower hiring and AI-linked layoffs, though productivity gains offered a bright spot. Reinking flags the jobs report, expected Fed rate cuts, and inflation data as key drivers ahead.

AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.